Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor

BACKGROUND: Most adoptive cell therapies (ACTs) suffer from an inability to control the therapeutic cell’s behavior following its transplantation into a patient. Thus, efforts to inhibit, activate, differentiate or terminate an ACT after patient reinfusion can be futile, because the required drug ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Boning, Napoleon, John Victor, Liu, Xin, Luo, Qian, Srinivasarao, Madduri, Low, Philip S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604868/
https://www.ncbi.nlm.nih.gov/pubmed/33127654
http://dx.doi.org/10.1136/jitc-2020-000756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604868/
https://www.ncbi.nlm.nih.gov/pubmed/33127654
http://dx.doi.org/10.1136/jitc-2020-000756

Ejemplares similares